MENU

NRIX Nurix Therapeutics Forecast, Technical & Fundamental Analysis

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases... Show more

NRIX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
NRIX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

NRIX is expected to report earnings to fall 101.82% to -8 cents per share on February 17

Nurix Therapeutics NRIX Stock Earnings Reports
Q4'26
Est.
$-0.09
Q3'26
Beat
by $5.34
Q2'26
Missed
by $0.09
Q1'26
Missed
by $0.03
Q4'25
Beat
by $0.10
The last earnings report on October 12 showed earnings per share of $4.73, beating the estimate of -61 cents. With 1.64M shares outstanding, the current market capitalization sits at 2.46B.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GLL25.680.75
+3.01%
ProShares UltraShort Gold (GLL)
APRH24.83-0.01
-0.06%
Innovator Premium Income 20 Barrier ETF - April (APRH)
WDAI28.17-0.38
-1.32%
Pacer S&P World 3AI Top 300 ETF (WDAI)
SRVR27.94-0.69
-2.41%
Pacer Data & Infrastructure Real Estate ETF (SRVR)
IWC174.88-4.72
-2.63%
iShares Micro-Cap ETF (IWC)

NRIX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been loosely correlated with KYMR. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
+6.96%
KYMR - NRIX
59%
Loosely correlated
+0.14%
GPCR - NRIX
47%
Loosely correlated
-1.93%
SVRA - NRIX
44%
Loosely correlated
-0.42%
AGIO - NRIX
44%
Loosely correlated
+2.52%
KURA - NRIX
44%
Loosely correlated
-2.24%
More
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders

Industry Biotechnology

Industry
N/A
Address
1600 Sierra Point Parkway
Phone
+1 415 660-5320
Employees
317
Web
https://www.nurixtx.com
Nurix Therapeutics (NRIX) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com